bio-regulatory-affairs-995x60
WHITE PAPERS & CASE STUDIES
-
Cell Line Development For High-Titer Lentivirus Vector Production
Explore a groundbreaking method to significantly enhance LV vector yield using engineered HEK293T cells. This approach paves the way for more efficient and large-scale production of LV vectors.
-
How Vanguard Clinical Harnesses CDMS/EDC For Faster Results
Uncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.
-
Transferring From Microfluidics To A Turbulent Mixer
What solutions did the client featured in this case study find when they sought help in transferring their formulation process to a turbulent Impinged Jet Mixing (IJM)?
-
Manufacturing Transfers: Delivering 140+ Precision Medical Devices Without Missing A Deadline
Go inside a successful manufacturing transfer of over 140 Class-III silicone medical devices and on-time delivery for a top-30 OEM through expert project management and rigorous validation processes.
-
ATAD Provides Increased Capacity With No Odors
Faced with persistent odor complaints and limited space, Douglas County Sewer District #1 in East Wenatchee, Washington, turned to the ThermAer second-generation Autothermal Thermophilic Aerobic Digestion (ATAD) system to modernize its biosolids treatment.
-
AMERICAN SpiralWeld Pipe Delivers For City Of Phoenix Drought Pipeline Project
Phoenix’s Drought Pipeline Project, supported by AMERICAN SpiralWeld Pipe, secures clean water for North Phoenix, delivering up to 75 million gallons daily and earning top industry awards.
WEBINAR
-
Non-animal-origin squalene is gaining momentum in vaccine adjuvants. See how fermentation-derived squalene delivers comparable performance, strong stability, and regulatory alignment.
-
Discover how incremental steps in digitalization and Data Integrity by Design can bridge the gap to Pharma 4.0, enhancing process efficiency and workforce capability without the need for a total overhaul.
-
Explore strategies for scaling MSC manufacturing while mitigating biological and operational risks. Learn how closed-system platforms and optimized workflows accelerate the path to commercial cell therapy.